BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 6, 2005
View Archived Issues
Oncolytic effects result from NF-kappaB blockade
Read More
Hybridon and Novartis to develop TLR9 drug candidates for asthma and allergy
Read More
Dual targeting with quinolones reduces the emergence of resistant Staphylococcus aureus
Read More
Studies describe the potential use of vatalanib for allograft rejection
Read More
Pirfenidone shows promise for lung transplant-associated obliterative bronchiolitis
Read More
New data on the benefits of alprostadil in women with FSAD
Read More
Clinical evidence supports the use of ambrisentan in PAH
Read More
Promising results obtained with an oral formulation of treprostinil
Read More
Rimonabant under clinical evaluation for maintaining smoking cessation
Read More
New data on the effects of TH-9507 in COPD
Read More
New phase I study for CHIR-258 in multiple myeloma
Read More
Ferring submits IND for female infertility product
Read More
Angiotech licenses ChondroGEL to Histogenics for cartilage repair
Read More
Novartis inlicenses Anadys' ANA-975 for HCV
Read More
European orphan drug designation for Proxinium
Read More
Phase II study for Ventavis in pulmonary hypertension associated with IPF
Read More
DCVax-Brain cleared for phase II GBM trial
Read More
Phase II study for 131I-TM-601 in glioma
Read More
Novel antiinfective agents disclosed in recent patent literature
Read More
Phase III trials begin for epratuzumab in lupus
Read More
IR-103 to be studied in drug naive HIV patients
Read More
Albuferon enters phase II study in combination with ribavirin for HCV
Read More
Novel 5-HT2C receptor agonist developed at Lilly
Read More
Japanese approval for Navelbine for inoperable or recurrent breast cancer
Read More
First phase IIb data on the therapeutic E1 vaccine for HCV infection
Read More
Vernalis and Serono jointly discover new matrix metalloproteinase inhibitors
Read More
Results of phase Ia trial of CTA-018 in psoriasis reported
Read More
CTCE-0214 induces stem cell mobilization in a phase I study
Read More
INS-50589 Antiplatelet well-tolerated, pharmacologically active in phase I study
Read More